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The activation of glucocorticoid receptors (GR) by glucocorticoids increases stress-related
memory through the activation of the MAPK signaling pathway and the downstream
transcription factor Egr-1. Here, using converging in vitro and in vivo approaches,
respectively, GR-expressing cell lines, culture of hippocampal neurons, and GR genetically
modified mice (GR
NesCre), we identified synapsin-Ia/Ib as one of the effectors of the
glucocorticoid signaling cascade. Stress and glucocorticoid-induced activation of the GR
modulate synapsin-Ia/Ib through two complementary mechanisms. First, glucocorticoids
driving Egr-1 expression increase the expression of synapsin-Ia/Ib, and second, glucocorti-
coids driving MAPK activation increase its phosphorylation. Finally, we showed that blocking
fucosylation of synapsin-Ia/Ib in the hippocampus inhibits its expression and prevents the
glucocorticoid-mediated increase in stress-related memory. In conclusion, our data provide a
complete molecular pathway (GR/Egr-1/MAPK/Syn-Ia/Ib) through which stress and glucocorti-
coids enhance the memory of stress-related events and highlight the function of synapsin-Ia/Ib
as molecular effector of the behavioral effects of stress.
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Introduction
Glucocorticoid hormones are released by the adrenal
glands during the active phase of the circadian cycle
and in response to stress.
1–4 Stress-induced high
levels of glucocorticoids have been shown to increase
the memory of stress-associated events
5–8 and to
contribute to the development of stress-related
pathologies such as depression, anxiety, and drug
abuse.
1,3–6,9,10 Most of these behavioral effects of
stress-induced glucocorticoid secretion depend on
the activation of glucocorticoid receptors (GR).
11 GR
are steroid-regulated transcription factors, which on
binding to glucocorticoids are translocated to the
nucleus in which they modify transcription by
multiple mechanisms.
12 Consequently, identifying
the transcriptional targets of stress-induced activation
of GR is paramount in uncovering the molecular basis
of stress-related disorders.
In an earlier paper, we described how activated GR
enhance fear memories by inducing a cascade of
events that starts with increasing the expression of the
transcription factor Egr-1 followed by an increase in
expression and activity of the MAPK pathway, which
further enhances the expression of Egr1.
8 These
effects were observed in the hippocampus, one of
the main brain targets of glucocorticoids that is
crucial for the encoding of memory.
5,6 The GR/Egr-1/
MAPK was the first molecular cascade subserving the
enhancement of stress-related memory to be identi-
fied.
8 Unfortunately, this cascade starts with a
transcriptional factor, GR, and ends up with another
transcription factor, Egr-1.
8 Consequently, the ulti-
mate effector proteins through which stress induces
an enhancement of memory still remain unknown.
In this report, we show that, in the hippocampus,
synapsin-Ia/Ib isoforms are one of the effector
proteins through which the GR/Egr-1/MAPK cascade
enhances stress-related memories. Synapsin-Ia/Ib are
the most highly expressed hippocampal pre-synaptic
vesicle (SV)-associated phosphoproteins.
13,14 The
mammalian synapsin family is composed of three
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spliced to give rise to two isoforms a and b regulated
by phosphorylation.
13 Synapsins control the release
of neurotransmitters, such as glutamate, which has a
crucial function in synaptic plasticity.
15–17 These
proteins have also been involved in the memory
process in drosophila and in aging-related memory
impairment in mammals.
18–20 However, the function
of the different synapsin isoforms in the formation of
specific types of memories remains unknown.
The expression of synapsin-Ia/Ib and their phos-
phorylation counterparts in response to glucocorti-
coids was studied using PC12 cell lines that express
both endogenous GR and synapsin isoforms,
21,22
primary culture of hippocampal neurons, as well as
the hippocampus of GR genetically modified mice
(GR
NesCre) in which the expression of GR has been
conditionally suppressed.
8,12,23 The function of sy-
napsin-Ia/Ib on stress-related memory was investi-
gated using 2-deoxy-D-galactose (2-dGal), an inhibitor
of synapsin-Ia/Ib expression.
24
Our results show that the GR/Egr-1/MAPK signal-
ing cascade increases stress-related memories through
synapsin-Ia/Ib. GR-activated Egr-1 increases the ex-
pression of synapsin-Ia/Ib, the function of which is to
enhance the pool of readily releasable SVs. GR-
activated MAPK then increases synapsin phosphor-
ylation, the function of which is to induce neuro-
transmitter release. Finally, inhibition of GR-induced
increase in hippocampal synapsin-I expression
abolishes the enhancement of stress-related memories
mediated by the GR/Egr-1/MAPK signaling pathway.
Together, our studies identify a complete molecular
pathway (GR/Egr-1/MAPK/Syn-Ia/Ib, GEMS) enhan-
cing the consolidation of stress-related memory and
highlight the important function of synapsin-Ia/Ib as
an effector of the behavioral effects of glucocorticoids.
Materials and methods
Study of the interaction between GR and synapsin
in vivo
For all the experiments, 5–6-week-old mice were fed
ad libitum and maintained in a temperature (22±11C)
and humidity (60±5%)-controlled environment un-
der a 12-h light/dark cycle (lights on at 0800 hours).
The gr gene (also called Nr3c1) was knocked out using
the Cre-LoxP recombination system in which the Cre
recombinase under the control of the rat nestin
promoter and enhancer allows GR
LoxP allele excision
in the entire brain of mutant mice,
23 but not in other
tissues. Control littermates not expressing Cre were
GR
LoxP/LoxP mice. Experiments carried out in basal
conditions compared GR
LoxP/LoxP and their littermates,
GR
NesCre mice. The mice were killed when glucocorti-
coid levels were low (beginning of the inactive phase
of the light cycle (0900 hours)). For the stress
experiments, GR
LoxP/LoxP (n=4) and GR
NesCre (n=4)
mice were subjected to a 30-min restraint stress and
killed either in basal conditions (t0) or 30 and 120min
after stress onset. Then, the hippocampus and blood
were collected, respectively, and assayed either for
protein extraction or for corticosterone assay. All the
experiments were conducted in strict compliance
with the European Communities Council Directive of
24 November 1986 (86/609/EEC) and approved by the
Aquitaine-Poitou Charentes ethical committee.
Chemicals
The corticosterone used in the various experiments
was from Sigma (C-2505, St Louis, MO, USA).
Corticosterone was used at 10nM in PC12 cells and
at 100nM in primary culture of hippocampal neurons.
The latter concentration was chosen on the basis of
preliminary experiments showing that 100nM corre-
sponded to the EC100 for the nuclear translocation of
the GR in this cellular model. MEK1/2 inhibitor
(UO126, 9903, Cell Signaling Technology, Danvers,
MA, USA) at a final concentration of 10mM was used
to block the MAPK signaling pathway. 2-dGal
(259580, Calbiochem, Gibbstown, NJ, USA), acting
as an inhibitor of synapsin fucosylation, was used at a
final concentration of 400mM per hemisphere.
Cell culture and transient siRNA transfection
The PC12 cell line (ATCC CRL-1721, Manassas, VA,
USA) derived from a transplantable rat pheochromo-
cytoma was used. The PC12 cells were trypsinized
and seeded on poly-D-lysine-coated wells to the
appropriate concentration (9 10
5 cells per well) in
fresh, antibiotic-free medium (15% horse serumþ
2.5% fetal bovine serum). Transfections of siRNA ON-
TARGETplus SMARTpool against Egr-1 (10nmol, L-
100247-01-0010, Dharmacon, Lafayette, CO, USA),
siRNA-negative control ON-TARGETplus siCON-
TROL non-targeting pool (10nmol, D-001810-10-05,
Dharmacon), and siRNA-Alexa Fluor 546 (1027098,
Qiagen, Duesseldorf, Germany) were performed with
Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA)
within OPTI-MEM medium (Invitrogen) according to
the manufacturer’s instructions at a final ratio of 1:1.
The percentage of transfection efficiency realized
with siRNA-Alexa Fluor 546 was determined by flow
cytometry (FACS Calibur, BD, USA). Then 6h after
transfection, the OPTI-MEM medium was changed for
a steroid-free culture medium. After 65h post-trans-
fection, the cells were treated for 1h with 10nM of
corticosterone-hydroxypropyl-b-cyclodextrin (Sig-
ma); proteins were extracted with RIPA buffer con-
taining protease and phosphatase inhibitors and
subjected to western blot analysis.
Cultures of hippocampal neurons prepared from
E18 Sprague–Dawley rats were plated at a density of
200 10
3 cells per ml on poly-lysine pre-coated
coverslips.
25 Cultures were maintained in serum-free
N2 medium
26 and kept at 36.51C in 5.0% CO2 for 7–9
days in vitro before transfection. Neuronal Egr-1
down-regulation by RNA interference was performed
by co-transfecting EGFP cDNA (1.6mg) as a reporter
and RNA duplexes (2.4mg) with Lipofectamine 2000
(15ml, Invitrogen) according to the manufacturer’s
instructions. Neurons were incubated for 1h with this
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after transfection, the neurons were treated for 1h
with 100nM of corticosterone-hydroxypropyl-b-cyclo-
dextrin (Sigma) and then siRNA efficiency was
checked by immunostaining.
Immunostaining
Neurons were fixed with 4% paraformaldehyde
(10min room temperature), washed, and permeabi-
lized using 0.1% Triton-X 100 (5min room tempera-
ture; Sigma). The cells were incubated with primary
antibodies for 1h and then with secondary antibodies
for 30min at room temperature. After washing,
neurons were mounted with Mowiol (Calbiochem)
or ProLong Gold Antifade Reagent containing DAPI
(Molecular Probes–Invitrogen, Eugene, OR, USA).
Preparations were kept at 41C until analysis.
GR immunoreactivity, Egr-1-immunoreactivity, and
synapsin-I-immunoreactivity were revealed using a
rabbit polyclonal anti-GR antibody (sc-1004-X, 1/500,
Santa Cruz, Santa Cruz, CA, USA), a rabbit polyclonal
anti-Egr-1 antibody (ARP32241_P50, 1/500, Aviva
System biology, CA, USA) and a mouse monoclonal
anti-synapsin-I (106001, 1/400, SYSY: Synaptic Sys-
tem, Germany), respectively. Secondary antibodies
with fluorescent labels were from Molecular Probes
(UK). Microscopic imaging was performed using an
upright epi-fluorescence microscope Leica DMR
(Leica Microsystems, Wetzlar, Germany) equipped
with objective HCX PL APO 63X oil NA 1.32 and a
CoolSnapHQ camera (Roper Scientific, Evry, France).
Quantification of the fluorescence was realized using
imaging tools from Metamorph software (Universal
Imaging Corporation, PA, USA).
Protein extraction from cell culture and tissues
Nuclear and cytoplasmic protein extracts from
PC12 cell lines and from mice hippocampi contain-
ing protease and phosphatase inhibitors (Sigma)
were prepared either using a procedure earlier
described and validated
27 or using the homogenizer
Precellys 24, which is a benchtop device dedi-
cated to the grinding, lysis, and homogenization of
biological samples (Bertin Technologies, Montigny-
le-Bretonneux, France). The homogenizing proto-
col in RIPA buffer containing protease and
phosphatase inhibitors was 5000r.p.m. 2 30þ
10s break using ceramic CK14 beads (Bertin
Technologies).
Immunoblotting analysis
Cytoplasmic and nuclear proteins suspended in
Laemmli buffer were separated by SDS–PAGE (10%
gels) and transferred onto PVDF membranes (Immo-
bilon P, IPVH00010, Millipore, Billerica, MA, USA).
The proteins were revealed with relevant antibodies
as described earlier.
27 The following Santa Cruz
polyclonal antibodies were used: anti-GR (sc-1004-
X; 1/50000 dilution), anti-Egr-1 (sc-189; 1/1000
dilution), anti-Synapsin-Ia/Ib (sc-8295; 1/2000 dilu-
tion), anti-Synapsin-IIa (sc-8293; 1/2000 dilution),
and anti-Synapsin-IIIa (sc-8292; 1/350 dilution).
Aviva System biology supplied the rabbit polyclonal
anti-Egr-1 (ARP36841_T100; 1/4000 dilution). BD
Biosciences (Franklin Lakes, NJ, USA) supplied the
monoclonal anti-Synapsin-I (611392; 1/10000 dilu-
tion) and anti-Synapsin-IIa (610666; 1/2000 dilution).
Upstate (Charlottesville, VA, USA) supplied the
polyclonal anti-MAPK (06-182; 1/100000 dilution).
Polyclonal anti-Phospho-MAPK (9101S; 1/1000 dilu-
tion) and Phospho-Synapsin (2311; 1/1000 dilution),
and Pan-synapsin (2312; 1/2000 dilution) were from
Cell Signaling Technology. The Neuronal Class III
b-tubulin (TUJ1) monoclonal antibody (MMS-435P;
1/20000 dilution) was purchased from Eurogentec
(Seraing, Belgium). The X-ray films (Kodak, USA)
were quantified by densitometry using a GS-800
scanner (in transmission mode) and the associated
Quantity One software (Bio-Rad, CA, USA) according
to the manufacturer’s instructions.
Corticosterone assay
Plasma corticosterone was quantified by radioimmu-
noassay using a specific corticosterone antibody (ICN
Pharmaceuticals, CA, USA) as described elsewhere.
27
Behavioral experiments
Subjects and surgery. C57/Bl6 male mice (n=69, 3–4
months old (IFFA Credo, Arbresle, France) were
anesthetized with ketamine/xylazine (Bayer,
Leverkusen, Germany) (8mlkg
–1, intra-peritoneally).
Using a Kopf stereotaxic apparatus, stainless-steel
guide cannulae (26-gauge, 8mm length) were
implanted bilaterally 1mm above the dorsal hippo-
campus and fixed in place with dental cement. Mice
were allowed to recover for at least 8 days before the
behavioral experiments.
Contextual fear conditioning procedure. All
experimental procedures took place during the light
portion of the light/dark cycle. Mice were handled
daily for 5min 3 days before the start of the contextual
conditioning procedure. This behavioral procedure
has been repeatedly used and fully described in
earlier studies.
8,28 Briefly, each animal was placed in
the conditioning chamber for 4min during which it
received two footshocks, which never co-occurred
with two tone (63db, 1kHz, 15s) delivery. Each
animal was then returned to its home cage. Twenty-
four hours later, the mice were re-exposed to the
conditioning chamber and the behavior of the
subjects was continuously recorded on videotape -
for off-line scoring of freezing. The conditioning
procedure consisted of a tone (CS)-shock (US) un-
pairing known to favor a context-US association.
28
Animals received one of two shock regimens: either
0.3mA, 50Hz, 3s (low shock intensity group) or
0.7mA, 50Hz, 3s (high shock intensity group).
Freezing behavior, used as an index of conditioned
fear, was calculated as a percentage (±s.e.m.) of the
total time spent freezing during the first 4min-period
of the retention test.
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fear conditioning, animals were placed in their home
cage and randomly divided into four groups according
to the intra-hippocampal infusion they received: (1)
vehicle (1% DMSO in artificial cerebrospinal fluid),
(2) corticosterone (10ng per side), (3) 2-dGal (400mM
per side), and (4) corticosteroneþ2-dGal. Infusions
(0.3ml per hemisphere) were performed at a constant
rate (0.1mlmin
–1) through 32-gauge stainless-steel
cannulae (9mm) that were inserted into the guide
cannulae and left in place for 2min after the end
of the infusion. Corticosterone (2-hydroxypropyl-b-
cyclodextrin complex; Sigma-Aldrich, St Louis,
MO, USA) and 2-dGal were dissolved in artificial
cerebrospinal fluid (145mM NaCl, 2.7mM KCl, 1mM
MgCl2, 1.2mM CaCl2, and 0.2mM Na2HPO4/NaH2PO4
buffered at pH 7.4).
Histology. After completion of the behavioral study,
animals were given an overdose of ketamin (24mlkg
–1)
and transcardially perfused with physiological saline,
followed by 10% buffered formalin. Brains were post-
fixed in formalin-saccharose 30% solution for 1 week,
frozen, cut coronally on a sliding microtome into
50mm sections that were mounted on a gelatin-coated
slide and stained with thionine to evaluate the
cannulae placements.
Statistics
Statistical analyses were performed using analysis of
variance (ANOVA) followed by the Newman–Keuls,
Duncan, or Scheffe post hoc test for pairwise
comparisons when appropriate. The Student’s t-test
was used for pairwise comparisons.
Results
GR in the hippocampus regulate synapsin-I expression
and phosphorylation
Using western blot, we compared the expression of
members of the synapsin family in the hippocampus
of GR
NesCre mice, in which the expression of the GR
protein is suppressed in the entire brain, but not in
other tissues using the Cre/LoxP system
23 and in
control littermates.
In basal conditions, using pan-synapsin, an anti-
body that detects all synapsin isoforms, we found a
reduced expression of these proteins and of their
phosphorylated counterparts in GR
NesCre mutant mice.
However, when more specific antibodies were used,
we found a selective decrease in the expression of
synapsin-Ia/Ib, but not of synapsin-IIa and -IIIa
(Figure 1a and b). Finally, levels of the transcription
factor Egr-1 were also reduced in GR
NesCre mutant
mice.
8
As, under physiological conditions, activation of
the GR is mainly obtained during stress, we also
analyzed changes in synapsin levels after an acute
restraint stress (30min). For this experiment, blood
and hippocampal extracts were collected before stress
(t0) and 30 or 120min after stress onset. As earlier
shown in wild-type animals, stress induced the
translocation of the GR and the expression of Egr-1.
8
In addition, stress also induced an increase in the
expression and phosphorylation of pan-synapsin as
well of synapsin-Ia/Ib, synapsin-IIa, and synapsin-IIIa
(Figure 1c). In GR
NesCre mutant mice, lacking the GR,
stress-induced expression of Egr-1 was profoundly
decreased. In addition, stress-induced increase in
phosphorylated synapsin was suppressed and the
increase in the expression of synapsin-Ia/Ib was
greatly reduced. In contrast, expression of synapsin-
IIa and -IIIa were not significantly modified by the
absence of the GR (Figure 1c).
These modifications of synapsin and Egr-1 levels
were not due to a decrease in stress-induced gluco-
corticoid secretion in mutant animals. Thus, as has
been shown several times,
8,23 basal and stress-
induced glucocorticoid levels were higher in GR
NesCre
mice (Table 1), indicating that the glucocorticoid-
negative feedback loop is profoundly impaired in GR
mutant mice.
These results indicate that both in basal conditions
and after stress, GR positively control the phosphoryla-
tion of synapsin and the expression of synapsin-Ia/Ib,
but not of other members of this family. Through this
double effect, GR may powerfully increase neurotrans-
mitter release. Indeed, the levels of synapsin-Ia/Ib
positively control the pool of readily releasable
SVs
17,29,30 and the phosphorylation of synapsin triggers
neurotransmitter release.
29
Glucocorticoid-induced synapsin-I phosphorylation
depends on MAPK activity
In the hippocampus in basal conditions (Figure 1a
and b) and after stress (Figure 1c), GR regulate the
expression of both Egr-1
8 and synapsin-I. As GR are
phasically activated by the increase in circulating
glucocorticoids that occurs during the active phase of
the circadian cycle or in response to stress,
1,2,5 we
analyzed whether the acute administration of gluco-
corticoids would stimulate the expression of synap-
sin-I. For this experiment, we used the PC12 cell line,
which expresses the GR and synapsin-I and -II
isoforms.
21,22 In this in vitro model, administration
of 10nM of corticosterone, which replicates the
concentration of the hormone induced by stress,
increases the expression of Egr-1, the phosphorylation
of synapsin, the expression levels of synapsin-I, but
not of synapsin-II (Figure 2a).
Phosphorylation of synapsin has a major func-
tion in controlling pre-SV trafficking by inhibiting
the dynamic association between the SVs and the
actin cytoskeleton.
13,29–32 We investigated here
whether GR-induced activation of the MAPK path-
way
8 was responsible for the GR-induced phos-
phorylation of synapsin-I. To test this hypothesis,
we studied glucocorticoid-induced phosphorylation
of synapsin-I in PC12 cells in the presence of a
selective inhibitor of MAPK phosphorylation,
UO126. UO126 was used at 10mM, a dose corres-
ponding to the EC100 of this compound (Figure 2b
and c).
33
Enhancement of stress-related memory by glucocorticoids depends on synapsin-Ia/Ib
J-M Revest et al
1143
Molecular PsychiatryPC12 cells were exposed for 1h to 10nM corticos-
terone in the presence or absence of UO126, after
which the proteins were extracted and analyzed by
western blot. In the absence of UO126, we found that
1h exposure to corticosterone induced both phos-
phorylation of the MAPK pathway (P-Erk1/2) and of
synapsin-I. Blocking the phosphorylation of the
MAPK pathway almost completely blocked the
phosphorylation of synapsin, but not the expression
of synapsin-I (Figure 2b and c).
Glucocorticoid-induced expression of synapsin-I
depends on Egr-1
In these experiments, we analyzed whether GR
increased synapsin-I expression through Egr-1. For
this purpose, we silenced Egr-1 expression by using a
small-interfering RNA strategy. PC12 cells were
transfected with siRNA (-ctrl or -Egr-1) 65h (t 65)
before exposure to 10nM corticosterone. After 1h of
exposure to corticosterone (t1), the cells were har-
vested and proteins immediately extracted (Figure 3a).
Figure 1 Comparison of the expression of the synapsin proteins family and Egr-1 under basal condition and after stress
between wild-type (WT) and GR
NesCre mice in which the glucocorticoid receptors (GR) were suppressed in the entire brain.
(a) Western blot analyses of hippocampus extracts for GR, Egr-1, phosphorylated-synapsin (P-synapsin), total synapsin
(Pan-synapsin), synapsin-Ia/Ib, synapsin-IIa, and synapsin-IIIa isoforms were performed using specific antibodies.
bIII-tubulin was used as a loading control. (b) Quantification by densitometry (optical density, OD, mean±s.e.m.) of the
corresponding X-ray films. Differences between WT (n=3) versus GR
NesCre (n=3) mice were all statistically significant,
*P<0.05, **P<0.005, ***P<0.001. (c) Stress-induced activation of the GR in the hippocampus stimulates synapsin-I
expression and phosphorylation. Comparison of the expression of synapsin isoforms in wild-type (WT) and GR
NesCre mice
lacking the expression of GR in neurons, before (t0) and 30 and 120min after the onset of 30min of restraint stress. bIII-
tubulin was used as a loading control. Nuclear (for GR and Egr-1) and cytoplasmic hippocampal extracts were analyzed by
western blot (left panel) and the corresponding X-ray films were quantified by densitometry (right panel, optical density, OD,
mean±s.e.m., n=6). *P<0.05; **P<0.005, ***P<0.001, WT versus GR
NesCre Newman–Keuls and Duncan post hoc test after
ANOVA.
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metry using siRNA-Alexa Fluor 546. With our proto-
col, it was possible to transfect 74% of PC12 cells with
siRNA, with no significant increase in cell death
(Figure 3b). Corticosterone increased both Egr-1 and
synapsin-I expressions in cells transfected with con-
trol siRNA. In contrast, in cells in which Egr-1
expression was silenced, the glucocorticoid-mediated
increase in synapsin-I expression was suppressed
(Figure 3c and d).
We then analyzed whether these effects could have
also been found in primary culture of hippocampal
neurons. We also found that, in this cellular context,
1h of corticosterone treatment promotes the nuclear
translocation of the GR proteins (Figure 3e) and a
concomitant and proportional increase in both Egr-1
and synapsin-I proteins (Figure 3f–i). Hippocampal
Table 1 Plasma corticosterone concentrations (mg per
100ml) induced by a 30-min restraint stress in control
littermate (WT) and GR
NesCre mice
Time (min) Plasma corticosterone
(mg per 100ml)
WT GR
NesCre
0 3.37±0.17 25.40±4.96
30 22.25±3.22** 51.77±6.93*
120 14.16±2.73* 39.89±0.99
Abbreviations: GR, glucocorticoid receptors; WT, wild type.
Blood was collected before the stress (t0), 30, and 120min
after stress onset. Values shown are mean±s.e.m.
*P<0.05, **P<0.001, compared with respective pre-stress
levels (t0).
Figure 2 Corticosterone-induced phosphorylation of synapsin-I involves the MAPK pathway. (a) Total extracts from PC12
cells were analyzed by western blot 1 and 3h after treatment with 10nM corticosterone. The corresponding X-ray films were
quantified by densitometry (optical density, OD, mean±s.e.m., n=3). *P<0.05; ***P<0.001, in comparison with basal
levels. (b) The effects of corticosterone administration (10nM) on Erk1/2, synapsin-I expressions, and their phosphorylated
counterparts were analyzed by western blot in PC12 cells exposed or not to the inhibitor of the MAPK pathway UO126
(10mM); 1h after the exposure to 10nM corticosterone, proteins were extracted and analyzed with relevant antibodies. bIII-
tubulin was used as a loading control. (c) Quantification by densitometry (optical density OD, mean±s.e.m., n=4) of the
western blot experiments. *P<0.05, **P<0.005, ***P<0.001 in comparison with untreated cells (ANOVA).
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-Egr-1) and EGFP 48h (t 48) before exposure to 1h of
100nM corticosterone. siRNA effects were checked by
immunostaining (Figure 3a, j–m). Silencing Egr-1
expression by RNA interference in hippocampal
neurons also suppressed the corticosterone-mediated
increase in synapsin-I expression (Figure 3j–m).
These results confirm that glucocorticoid-induced
expression of synapsin-I also depends on Egr-1 in
neuronal cells.
In conclusion, these results show that the GR/Egr-1/
MAPK cascade controls synapsin-I by complementary
mechanisms. Activation of Egr-1 by the GR specifi-
cally increases the levels of expression of synapsin-Ia/
Ib; in parallel, GR-induced MAPK activation induces
the phosphorylation of synapsin-I.
Synapsin-I mediates GR-induced enhancement of fear
conditioning
The earlier results suggest that synapsin-I could be
one of the molecular effectors through which activa-
tion of the GR/Egr-1/MAPK molecular cascade
enhances stress-related memories. To test this hypo-
thesis, we analyzed the effects of a modification of the
levels of expression of synapsin-I on the retention of
fear conditioning.
Synapsin-Ia/Ib has recently been shown to be the
major Fuca(1–2)Gal glycoprotein in the hippocam-
pus. Inhibiting synapsin-Ia/Ib fucosylation using
2-dGal critically impacts both its cellular half-life
expression and turnover in pre-synaptic nerve
terminals.
24,34
We, therefore, examined the effects of an intra-
hippocampal infusion of 2-dGal both on the expres-
sion of synapsin-I and on the enhancement of
hippocampal-dependent contextual fear condition-
ing
8,28 induced by corticosterone (Figure 4). Intra-
hippocampal infusion of corticosterone immediately
after training increased the conditioned fear induced
by an electric shock of low intensity (0.3mA
footshock) inducing a response similar to the one
obtained with an electric shock of high intensity
(0.7mA footshock) (Figure 4a). However, the enhan-
cing effect of corticosterone on contextual fear
conditioning was completely abolished when 2-dGal
(400mM per side) was infused concomitantly with
corticosterone (Figure 4a). To verify the effect of
corticosterone and 2-dGal infusion on synapsin-I, a
group of animals was killed 2h after the hippocampal
infusions. Hippocampal proteins were then extracted
and analyzed by western blot. We found that
hippocampal infusion of corticosterone stimulates
synapsin-Ia/Ib expression and that this increase was
largely blocked by 2-dGal infusion (Figure 4b).
In conclusion, these results indicate that synapsin-
Ia/Ib is one of the effectors through which the GR/
Egr-1/MAPK cascade enhances stress-related memory.
Discussion
The central finding of this work is the identification
of synapsin-Ia/Ib as an important molecular effector of
glucocorticoid-mediated behavioral effects of stress.
In particular, synapsin-Ia/Ib seems to be one of the
effectors through which the GR/Egr-1/MAPK cascade
enhances stress-related memory. Thus, combining
in vitro and in vivo approaches, we found that both
in basal conditions and after stress, GR, through the
activation of Egr-1 expression and MAPK phospho-
rylation, increase synapsin-Ia/Ib expression and
phosphorylation, respectively, and that these events
Figure 3 Corticosterone stimulation of synapsin-I expression depends on Egr-1. (a) Schematic illustration of the protocol
used to silence Egr-1 expression by using a small-interfering RNA strategy. PC12 cells and hippocampal neurons were
transfected with siRNA (-Egr-1, -ctrl, -Alexa Fluor 546, or EGFP); 48 to 65h later, the cells were exposed to corticosterone
(Cort) for 1h and then proteins were analyzed by western blot (PC12) or immunostaining (neurons). (b) The transfection
efficiency in PC12 cells was evaluated by flow cytometry after transfecting siRNA-Alexa Fluor 546. (c) Western blot analyses
of the effects of corticosterone administration (10nM) on synapsin-I and Egr-1 expressions after silencing Egr-1 expression
using an siRNA strategy. bIII-tubulin was used as a loading control. (d) Quantification by densitometry (optical density OD,
mean±s.e.m., n=3) of the western blot experiments. *P<0.05, **P<0.005, in comparison with untreated cells (ANOVA). (e)
Immunostaining of hippocampal neurons cultured for 9 days in vitro showing the sublocalization of the GR proteins (green)
in the absence or presence of 100nM of corticosterone for 1h. Nuclei were counterstained with DAPI (blue). Merge of the two
signals is shown. Scale bar=25mm. (f) Co-immunolocalization of Egr-1 (green) and synapsin-I (red) proteins on hippocampal
neurons cultured for 9 days in vitro in the absence or presence of 100nM of corticosterone during 1h. Scale bar=25mm. (g, h)
Quantification of the fluorescence intensity (AU, arbitrary unit) of Egr-1 (g) and synapsin-I (h) -immunoreactive hippocampal
neurons in the absence or presence of 100nM of corticosterone (Cort) during 1h. (i) After corticosterone treatment, the
expression of Egr-1 and synapsin-I proteins in Egr-1-expressing hippocampal neurons increased proportionally. Values
shown are mean±s.e.m. **P<0.005, ***P<0.001, in comparison with untreated cells. (j) Immunofluorescence analysis of
hippocampal neurons treated with corticosterone (100nM) for 1h and earlier co-transfected with EGFP cDNA and siRNA
control or siRNA silencing Egr-1 protein. Nuclei were counterstained with DAPI (blue). The white arrows show the mapping
of the synapsin-I protein in EGFP-positive hippocampal neurons transfected either with siRNA-ctrl or siRNA-Egr-1.
Scale bar=25mm. (k, l) Quantification of the fluorescence intensity (AU, arbitrary unit) of Egr-1 (k) and synapsin-I
(l) -immunoreactive hippocampal neurons transfected with siRNA-ctrl or siRNA-Egr-1 in the presence of 100nM of
corticosterone (Cort) during 1h. (m) Proportional decrease between Egr-1 and synapsin-I proteins in neurons in which Egr-1
expression was silenced compared with siRNA-ctrl transfection. Values shown are mean±s.e.m. **P<0.005, ***P<0.001,
in comparison with siRNA-ctrl transfected cells.
Enhancement of stress-related memory by glucocorticoids depends on synapsin-Ia/Ib
J-M Revest et al
1146
Molecular Psychiatrywere necessary for the increase in stress-related
memories induced by glucocorticoids.
With the results of the present experiment extend-
ing those published in an earlier paper, we can single
out a complete molecular cascade that is involved in
the mediation of stress-related memory (Figure 5). We
have earlier shown that stress-induced glucocorti-
coids increase stress-related memories by activating
the GR, which trigger a cascade of events starting with
an increase in the expression of the transcription
factor Egr-1 and followed by the activation of the
MAPK pathway.
8 We show here that the activation of
Egr-1 by glucocorticoids increases the level of synap-
sin-I and that the activation of the MAPK pathway
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cing Egr-1 expression thus represses the increase in
synapsin-Ia/Ib expression induced by glucocorticoids
both in PC12 cells and in primary culture of
hippocampal neurons. This effect is probably a direct
one, as Egr-1 binds to responsive elements in the
promoter region of the syn1 gene and is able to
activate its transcription in vitro.
35–37 In parallel,
mitogen-activated protein kinase (Erk1/2) induces
the phosphorylation of synapsin-I, but does not
modify its expression. Thus, UO126-mediated block-
ade of MAPK phosphorylation largely reduced gluco-
corticoid-induced synapsin-I phosphorylation, but
did not change the expression of synapsin-I.
Synapsin-I undergoes several cycles of phosphor-
ylation/dephosphorylation on serine residues. In vitro
studies have shown that these phosphorylations can
involve many different kinases, including cAMP-
dependent protein kinase, Ca
2þ/calmodulin-depen-
dent protein kinase (CaMK) I, CaMK II, CaMK IV,
proline-directed kinase, mitogen-activated protein
kinase (Erk1/2), cyclin-dependent kinase 1 and 5,
tyrosine kinase c-Src, protein kinase C, and p21-
Figure 4 Synapsin-Ia/Ib mediates the enhancement of
contextual fear conditioning induced by glucocorticoids.
(a) Percentage of conditioned freezing (mean±s.e.m.)
displayed by mice re-exposed for 4min to the conditioning
context 24h after conditioning with either high (0.7mA
footshock; n=12) or low shock intensity (0.3mA footshock;
n=11) and receiving a post-training intra-hippocampal
infusion of either vehicle (n=11), 2-dGal (n=11; 400mM
per side), corticosterone (n=12; 10ng per side), or
corticosteroneþ2-dGal (n=12). (b) Western blot analysis
and quantification of synapsin-Ia/Ib hippocampal expres-
sion in the presence or absence of the inhibitor of
fucosylation 2-dGal (400mM per side). bIII-tubulin was
used as a loading control; 2h post-hippocampal infusion of
2-dGal, proteins were extracted, analyzed by western blot,
and quantified by densitometry (optical density OD,
mean±s.e.m., n=4). **P<0.005, ***P<0.0001, in compar-
ison with all the other groups, Newman–Keuls and Scheffe
post hoc test after ANOVA.
Figure 5 Schematic model of GEMS molecular cascade
mediating the enhancement of stress-related memories.
During stress, the increase in glucocorticoid secretion (1)
activates the glucocorticoid receptors (GR) inducing its
nuclear translocation (2). GR trigger the synthesis of the
transcription factor Egr-1 (3) and then the activation of the
MAPK pathway (4), which further increases Egr-1
production (5). Egr-1 stimulates the transcription of synap-
sin-Ia/Ib (6), which increases the number of SVs bound to
actin and in this way the pool of readily releasable
neurotransmitters. Activated MAPK do not modify synap-
sin-I expression, but induce their phosphorylation (7).
Phosphorylated synapsin-Ia/Ib releases SVs bound to actin
(8) allowing their transport to the pre-synaptic membrane
(9) and neurotransmitter release (10). The double action of
GR-induced Egr-1 expression and MAPK activation on
both synapsin-I synthesis and phosphorylation can guaran-
tee a sustained increase in neurotransmitter release.
Specifically, an increase in glutamate release is likely to
mediate the enhancement of stress-related memories that
can be blocked both by inhibiting MAPK phosphorylation
and synapsin-I expression. This model is based on
several studies, including ours, which are discussed in the
main text.
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13,14,30,38–40 It is unlikely that in vivo
all these kinases phosphorylate synapsin-I at the same
time; in all probabilities, their actions depend on the
type of stimulation.
30 Our results indicate that in vivo
the MAPK pathway has an important function in
stress-induced phosphorylation of synapsin-I.
Our data also show that the regulation of synapsin-I
by the GR/Egr-1/MAPK cascade increases stress-
related memory. Inhibition of synapsin-I expression
by 2-dGal thus abolished glucocorticoid-induced
increase in contextual fear conditioning. These
results extend earlier knowledge and start clarifying
the function of different synapsin isoforms in memory
formation. Thus, it has been earlier shown that
synapsin-deficient Drosophila melanogaster flies dis-
play a deficit in learning and memory,
20,41 and
synapsin-I null mice display an increase in age-
dependent cognitive impairments.
42 In parallel, the
learning of a spatial memory task increases expres-
sion of synapsin-I in the hippocampus,
19,43 and
transgenic mice expressing a constitutively active
form of H-ras (H-ras
G12V) exhibit increased
Erk-dependent phosphorylation of synapsin-I and
dramatic enhancements in hippocampus-dependent
learning that can be reversed by the deletion of
synapsin-I.
44 Our data indicate that synapsin-Ia/Ib
have an important function in the formation of
hippocampal-mediated stress-related memory.
As all the synapsin isoforms (-I, -II, and -III) are
expressed within the hippocampus,
14,45 it could be
argued that other synapsins could be modified by
2-dGal and consequently be involved in the modula-
tion of fear memory. In fact, synapsin fucosylation
sites are localized within the D domain of synapsin, a
region that is found only in the synapsin-Ia/Ib
isoforms and not in the other isoforms.
14 In addition,
western blot analysis of adult hippocampal lysates
from synapsin-I-deficient mice revealed a loss of the
fucosylated bands, confirming that synapsins Ia and
Ib are the predominant Fuca(1–2)Gal glycoproteins in
the hippocampus.
24
The inhibition of stress-related memory by blocking
synapsin-I fucosylation also supports growing evi-
dence, indicating that carbohydrate post-translational
modifications to N- and O-linked glycoproteins could
participate in cognitive processes such as learning
and memory
46,47 and in synaptic plasticity.
34,48,49
The GEMS cascade enhances stress-related memory
very likely by increasing the release of neurotrans-
mitters. Unphosphorylated synapsins bind SVs
tightly to actin. These synapsin-actin-bound SVs
constitute the readily releasable pool of vesicles that
is positively regulated by synapsin-I levels.
50 Phos-
phorylation of synapsin-I then releases SVs from the
synapsin-actin-bound state,
31 which in turn allows
their transport to the sites of exocytosis and the release
of neurotransmitters.
29,30 Consequently, the increase in
the level of synapsin-I induced by GR-induced Egr-1
will increase the stock of neurotransmitters readily
releasable, and its phosphorylation by GR-activated
MAPK triggers its actual release.
Several lines of evidences suggest that the enhance-
ment of stress-related memory mediated by the GEMS
pathway is mediated by glutamate release. First, in
the hippocampus, synapsin-I is exclusively expressed
in glutamatergic pyramidal neurons, but is absent
from GABA interneurons.
51–53 Second, intra-perito-
neal administration of corticosterone increases gluta-
mate, but not GABA release in the hippocampus.
54
This effect depends on GR activation, as it can be
prevented by pre-treatment with the GR antagonist
mifepristone.
55 Finally, synapsin-I has been shown to
regulate glutamate release from SVs
17 through a
synaptic activity-dependent mechanism
56 that is
impaired in mice lacking the synapsin-I gene.
16,17,57
An increase in glutamate release triggered by the
GEMS pathway can in turn modify synaptic plasti-
city, which is probably involved in the enhancement
of stress-related memory.
18
In conclusion, our data provide a complete mole-
cular pathway GEMS (Figure 5) through which
glucocorticoids can enhance the memory of stressful
events,
5–8 and reveal synapsin-Ia/Ib as an important
molecular effector of the behavioral consequences of
stress.
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